Hydrocortisone During Septic Shock to Prevent Later PTSD
Trial evidence in septic shock survivors links stress-dose hydrocortisone to fewer later PTSD symptoms, not just to hemodynamics. That finding is real but genuinely underused, since almost nobody prescribes a critical-care drug with a psychiatric endpoint in mind.
M.A. is a 61-year-old man, a retired postal worker, admitted to the ICU in septic shock secondary to a perforated diverticulum, now on hospital day two and requiring escalating norepinephrine to maintain his mean arterial pressure despite adequate fluid resuscitation and source control the previous evening. He has well-controlled type 2 diabetes and osteoarthritis, and lives with his wife, who has been at the bedside since admission and reports he has never previously been hospitalized for anything beyond a hernia repair years ago.
The intensivist raises stress-dose hydrocortisone for his refractory shock, which is a familiar, hemodynamically driven decision on its own. What is less familiar to most of the team is a separate line of evidence, distinct from the vasopressor-sparing rationale: a series of small studies in critically ill patients has found that those who received stress-dose hydrocortisone during their acute illness went on to report meaningfully fewer PTSD symptoms months later than those who did not. The septic-shock-specific evidence is the thinnest part of it — a matched case-control comparison of twenty-seven pairs, plus a small controlled follow-up — while the randomized data come mostly from cardiac-surgery populations rather than from sepsis. The proposed mechanism is that severe physiologic stress and the fragmented, often delirious memory encoding that accompanies critical illness may itself drive later traumatic-memory symptoms, and that glucocorticoid modulation during the acute stress response can blunt that specific process the same way it blunts the inflammatory one. For M.A., the decision to start hydrocortisone would be made on hemodynamic grounds regardless — the psychiatric benefit is a genuine bonus reason that almost never enters the conversation, because almost nobody managing septic shock is thinking about a psychiatric outcome six months away. His type 2 diabetes does not change that calculus, but it does mean the expected rise in blood glucose on stress-dose steroids needs to be anticipated and covered rather than discovered.
In the ICU
On hemodynamic grounds alone, he meets the standard criteria for stress-dose hydrocortisone: refractory shock despite adequate fluids and an escalating pressor requirement. That decision does not actually need the psychiatric data to be made — it is worth starting today regardless.
Agreed on the hemodynamic indication, but I think the psychiatric evidence deserves to be said out loud to the family, not just noted in passing. The signal linking stress-dose hydrocortisone to lower rates of later PTSD has appeared in more than one cohort — it is not the reason to start the drug, and the sepsis-specific studies are small and mostly not randomized, but it is a genuine second consideration his wife should hear about, given how frightening this admission has clearly been for both of them. I'd also get his insulin coverage adjusted in the same order set rather than after the first high stick.
The proposed mechanism — glucocorticoid modulation of stress-related memory encoding during critical illness, separate from its anti-inflammatory effect — is still being worked out, so I would frame this as a genuine but secondary reason for reassurance, not a guarantee.
That framing is the right one. I would also flag his intermittent delirium directly to his wife as part of the same conversation — disorganized, frightening memories of this admission are themselves a PTSD risk factor independent of the hydrocortisone question, and she should know that follow-up screening for PTSD symptoms after discharge is worth arranging regardless of how well the shock resolves.
Stress-dose hydrocortisone started for refractory septic shock, with the team explicitly discussing the additional psychiatric evidence with M.A.'s wife rather than treating it as a footnote.
Agreed by the whole team: the psychiatric benefit was real and worth naming, but never treated as the reason for the decision, since the hemodynamic indication stood on its own regardless of the PTSD-prevention data.